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Abstract Heart disease in women is associated with high
levels of morbidity and mortality. Although many of the
underlying causes are similar for both genders, cardiovas-
cular disease among women has some unique features,
including higher coronary heart disease mortality, higher
frequency of sudden cardiac death without previous
symptoms, and increased mortality among older women
compared to men following a myocardial infarction. During
recent years, increasing efforts have been placed on
identifying preventive measures, but translation of knowl-
edge from epidemiological studies and clinical trials remain
incomplete, particularly in women. The recent launch of the
National Institutes of Health’s Clinical and Translational
Science Award program offers opportunities to address
these gaps and represent a unique opportunity to foster a
new generation of researchers familiar with important




Heart disease is an important contributor to morbidity and
mortality among women. While many of the underlying
cardiovascular risk factors are similar for both women and
men, cardiovascular disease among women has some
unique features. These include a higher frequency of
women with sudden death without previous symptoms
and an increased mortality among older women compared
to men following a myocardial infarction [1–3]. These
factors may contribute to higher coronary heart disease
mortality in women compared to men, a fact not commonly
recognized by physicians [1, 4]. During recent years,
increasing efforts have been placed on identifying preven-
tive measures, and in 2007, an update on evidence-based
guidelines for cardiovascular disease prevention in women
was published [3]. However, sufficient translation of
knowledge from epidemiological studies and clinical trials
into clinical practice is lacking, particularly among women
who might be unaware that they are at risk. The recent
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Sacramento, CA, USAlaunch of the National Institutes of Health’s Clinical and
Translational Science Award (CTSA) program offers
opportunities to address these gaps. The CTSA program
has already had a profound impact on clinical research and
training methods related to women’s health issues at the
University of California, Davis (UC Davis) [5–7].
UC Davis was among the first 12 institutions to receive
NIH funding for a CTSA and created its Clinical and
Translational Science Center (CTSC) in 2006 [7, 8]. The
funding accelerated and further integrated an existing
conscientious planning effort for translational research with
a stepwise approach to gradually increase our institutional
competencies, capabilities, and resources in this area. The
development of our CTSC has led us to develop new ways
of bringing together a diverse faculty and facilitating
research. In particular, the CTSC has impacted on our
research training programs, providing a pathway to fully
integrate trainees across the translational spectrum.
Cardiovascular Disease in Women—Current Issues
Although considerable progress has been made for disease
prevention as well as therapeutic intervention in the area of
cardiovascular health, heart disease remains a particular
challenge for women. Women have a higher mortality rate
after an initial myocardial infarction than men, and the
majority of women suffering from an acute cardiovascular
event do not make a full recovery. Further, the vast majority
of middle-aged women have at least one risk factor for
heart disease [2]. Although cardiovascular disease can, to a
large extent, be prevented by attention to established risk
factors, many women are unaware that they are at risk [9].
Assessment of cardiovascular risk in the USA is firmly
based on application of the Framingham risk score system,
and this system often underestimates the actual cardiovas-
cular risk in women [10]. In addition, a recent study
demonstrated a higher relative risk for coronary heart
disease related to the commonly occurring metabolic
syndrome among women compared to men [11]. Further,
the nature of disease manifestations as well as clinical
symptoms may differ across gender. Thus, among women,
the atherosclerotic process is more distributed in the
vascular tree, and symptoms such as fatigue, dyspnea, and
shoulder or neck pain are more commonly associated with
myocardial infarction than in men, contributing to a greater
diagnostic challenge [12].
Beyond gender issues, there are differences in risk factor
distribution and disease management across ethnicities. For
example, African American women have a higher rate of
coronary heart disease and cardiovascular disease, which
constitutes a higher fraction of deaths in this group
compared to other minorities [13]. Further, while the
metabolic syndrome represents an increased risk for heart
disease across Caucasian–African American ethnicity, the
individual components of the syndrome is distributed
differently [14].
Differences in cardiovascular disease manifestation and
presentation, risk factor assessment, pathophysiologic fac-
tors, and therapeutic strategies across gender have not been
fully addressed. To resolve these remaining challenges,
progress across the entire translational spectrum from basic
science to population intervention(s) is required. Educa-
tional and research infrastructure initiatives such as the NIH
“Building Independent Research Careers in Women’s
Health” (BIRCWH) and related CTSA programs represent
excellent opportunities to prepare a new generation of
researchers with a rich array of tools to help resolve these
important issues.
Integrated Training in Translational Science—Focus
on Women’s Health
The CTSA program has created an integrated academic
home for clinical and translational science with the
resources and infrastructure to train and advance multi-
and inter-disciplinary investigators and research teams. The
UC Davis CTSC Research Education, Training, and Career
Development program is committed to a comprehensive
approach to translational research training that provides
scholars with a rich array of career development opportu-
nities through program curricula, mentored research train-
ing, and partnerships with other programs, departments, and
institutions. We aspire to transform clinical and translation-
al research training and career development across UC
Davis by serving as a resource for best practices, including
sharing the many resources created through the CTSC. A
strong pipeline and the recognition of a research training
culture are clearly emerging, and the CTSC serves as a
clinical and translational “research incubator” that incorpo-
rates education, clinical and translational resources, and
informatics to facilitate novel research initiatives and
promote gains in cardiovascular disease prevention (Fig. 1).
The UC Davis BIRCWH program is a key CTSC partner
in achieving the goals of team-based training. The
overarching objective of the BIRCWH program is to
provide junior faculty with state-of-the-art multidisciplinary
training that will ensure that they establish independent
biomedical research careers in areas relevant to women’s
health. A second objective of this program is to create an
environment that nurtures non-traditional cross-disciplinary
collaborations in focused and interactive research areas that
are essential to improving the health of women, such as the
role of sex hormone levels and hormone replacement
therapy for cardiovascular health, cancer risk factors, and
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translational and preclinical assessments. From its incep-
tion, the UC Davis BIRCWH program has focused on four
interacting areas of women’s health, three of which are
highly significant in the prevention of cardiovascular
disease: (1) metabolic and nutrition-related syndromes and
their repercussions for women; (2) cardiovascular science
and its relationship to gender; and (3) lifespan biology and
transitions, such as early development, adolescence, and
menopause, that bring unique risks to females.
Through the partnership between the BIRCWH and the
CTSC training programs, an integration of curricula has
brought together clinical and basic science faculty, graduate
students, and medical students to work together as teams
and to learn from each groups’ perspectives and experi-
ences. As a result of these program experiences, scholars
are learning by working with colleagues in different
disciplines, with different research approaches, and at
different career stages. Bringing together scholars from
different career stages and disciplines has enriched these
learning experiences for all groups by presenting career role
models for junior scholars, providing mentoring opportuni-
ties for senior scholars, and exposing all scholars to unique
and diverse perspectives. Examples of such interactions
include CTSC scholars pursuing research projects that
focus on risk factor assessment and hormonal pathophys-
iology in women’s cardiovascular disease. Two research
projects investigate the roles of endogenous sex hormones
(1) in the risk of stroke and on the metabolic syndrome as a
risk factor across gender and ethnicity and (2) in the risk of
vascular dementia and in conjunction with abnormal
cerebral imaging in older affected adults. According to
recent clinical trials, women taking exogenous menopausal
hormones have an increase in the risk for strokes and no
clear coronary heart disease benefit, for currently unknown
reasons. The role of endogenous sex hormones in cardio-
vascular disease in older women is not well studied and
might contribute substantially to understanding these find-
ings and to determining women’s health overall. Certain
animal models such as the nonhuman primate model where
reproductive features directly parallel humans provide
unique opportunities to address this relationship and
provide a greater understanding of the menopausal transi-
tion and impact on healthy aging. CTSC scholars are
examining prospectively the roles of endogenous circulat-
ing levels of estrogens and androgens and of genetic
variations within the sex hormone metabolic pathways in
the development of stroke, coronary heart disease, and
components of the metabolic syndrome. CTSC scholars aim
to use newer methods to incorporate the metabolic interplay
between estrogens and androgens in their investigations.
They are comparing these relations between postmenopaus-
al women and age-comparable men of different ethnicities
since differences in sex hormone metabolism could explain
in part the gender and ethnic differences in cardiovascular
disease.
Another project example involves determining the
relation between endogenous sex hormones and abnormal
cerebral imaging in older women, compared with older
men, who have mild cognitive dysfunction or dementia due
to cerebrovascular disease. This prospective cohort study
resulted directly from an annual CTSC retreat that fostered
new collaborations between a CTSC scholar and members
of the UC Davis’ Alzheimer’s Disease Center, including
experts in neuropsychology, pathology, and neuroimaging.
These investigations implement the translational tools of
molecular and genetic epidemiology in large prospective
population studies. This strategy requires cross-disciplinary
collaborations between scholars, trained in endocrinology
and epidemiology, and experts in reproductive hormone
assays, genetic epidemiology, biostatistics, neuroimaging,
and neuropsychiatry. It fosters regular mentoring by CTSC
scholars of graduate students and medical fellows working
on such projects. This approach will be a key to scientific
advancement in understanding gender and ethnic differ-
ences in cardiovascular disease and identifying important
hormonal differences in the pathogenesis of cerebrovascular
disease and of coronary heart disease.
Prevention—Enhancement Through Translational
Approaches
From the inception of the CTSC, the program has focused
on providing key support functions to investigators in order
to enhance study initiation, increase the quality and























Fig. 1 UC Davis CTSC re-
search incubator used as a mod-
el to illustrate the translational
impact on studies on women’s
cardiovascular health. BIRCWH
Building Independent Research
Careers in Women’s Health,
WCMP Women’s Cardiovascu-
lar Medicine Program, PCIR
Participant and Clinical Interac-
tions Resources
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capabilities. An example of this approach is the support
provided from the UC Davis CTSC to the UC Davis
Women’s Cardiovascular Medicine Program. The overarch-
ing goal of this program is to provide women with
seamless, state-of-the-art, multidisciplinary cardiac health
services that comprehensively address the cardiovascular
needs of women. The UC Davis Women’s Cardiovascular
Medicine Program is focusing on five interactive compo-
nents of cardiovascular health: (1) education and awareness
of heart disease as the leading killer of women; (2)
screening and risk assessment to address the greater relative
risk of major risk factors for women; (3) diagnostic testing
and treatment with respect to gender; (4) lifestyle modifi-
cation and cardiac rehabilitation and its importance to
cardiovascular risk reduction; and (5) tracking and evalu-
ation, assessing success, and results for women. Impor-
tantly, the Women’s Cardiovascular Medicine Program has
demonstrated expertise in developing a regional model of
women’s cardiovascular healthcare serving women in
underserved areas, including rural northern California and
the central valley. The research activities in the program
have been supported by the CTSC, resulting in increased
opportunities to undertake community-based research stud-
ies due to the infrastructure provided by the CTSC, as well
as an ability to serve as coordinating center for multicenter
studies, as outlined below.
Another example of CTSA support for studies related to
women’s health are several investigations on nutritionally
based therapies for polycystic ovary syndrome undertaken
in the CTSC Clinical Research Center and supported by
CTSC informatics and biostatistics resources. The CTSC
support has allowed detailed mechanistic studies aimed at
cardiovascular risk factor intervention, including blood
lipid levels and the degree of insulin resistance [15, 16].
Informatics—A Key to Improved Prevention
Another significant component of the CTSA program is the
development and use of innovative research tools and
information technologies that promote application of new
knowledge and techniques to patient care. An example is
the support provided by the CTSC to the Women’s
Cardiovascular Medicine Program as part of an award from
the US Department of Health and Human Services Office
on Women’s Health entitled “Improving, Enhancing, and
Evaluating Outcomes of Comprehensive Heart Care Pro-
grams in High-Risk Women”. The CTSC partnership made
it possible for the UC Davis program to function as a data-
coordinating center for six geographically disperse sites,
including four academic health centers, one clinical practice
center, and one mobile community-based healthcare deliv-
ery program [17]. The purpose of the study was to evaluate
cardiovascular disease prevention, knowledge, risk aware-
ness, and clinical outcomes in high-risk women and to
compare outcomes at 6 and 12 months of patient follow-up.
The intervention involved patient education and the
application and utilization of the recently published
American Heart Association guidelines on “Evidence-
Based Guidelines for Heart Disease Prevention in Women”
[3]. Each participating site collected patient demographic,
survey, and clinical data on over 1,300 women during a
2-year period, involving collection of de-identified patient-
specific data from the six sites. These efforts illustrate the
synergistic potential of the nationwide CTSA program and
its opportunities to enrich specific intervention studies
addressing complex diseases, such as in the area of
gender-specific cardiovascular health and disease.
CTSA Facilitation of Research Initiatives
Identification of and support for research funding opportu-
nities represent an important mission of CTSAs. The UC
Davis CTSC Grant Facilitation Unit has provided the
Women’s Cardiovascular Medicine Program assistance with
several grant proposals. Some examples include (1) the
successfully funded proposal to the Department of Health
and Human Services for “Improving, Enhancing, and
Evaluating Outcomes of Comprehensive Heart Health Care
Programs in High-Risk Women” described above; (2) a
Women’s Career R01 that is pending award notification;
and (3) a Challenge Grant application that is part of the
American Recovery and Reinvestment Act through the
National Institutes of Health. By providing assistance with
these proposals, we have been able to help further
initiatives and projects aimed at cardiovascular research
goals in women’s health. Further, the creation of opportu-
nities for a broad spectrum of investigators to participate in
translational activities represents an important CTSA
mission and represents another example of how the CTSAs
can facilitate collaborative research efforts.
Summary
The CTSA program offers novel and far-reaching opportu-
nities to support clinical and translational research in
common and chronic disease areas. The many complexities
contributing to the currently distant goal of reducing
cardiovascular mortality among women suggest that this
area of research may in particular benefit from synergistic
interactions with the national CTSA programs. It is
apparent that the UC Davis CTSC has substantially
impacted clinical and translational research to a significant
254 J. of Cardiovasc. Trans. Res. (2009) 2:251–255extent at our institution, and, in the first 2 years, has
markedly transformed the ease and ability of UC Davis
researchers to engage in clinical and translational research.
Here, we have provided some examples that highlight the
potential of the program in its abilities to support, extend,
and enrich efforts to increase our understanding of and
ability to prevent cardiovascular disease in women.
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